VF
BIOA

Virtu Financial’s BioAge Labs BIOA Stock Holding History

Virtu Financial’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,911
Closed -$62K – 2204
2025
Q2 		$62K Buy
+14,911
New +$60.1K ﹤0.01% 1112
2025
Q1 		– Sell
-10,132
Closed -$59K – 2153
2024
Q4 		$59K Buy
+10,132
New +$175K ﹤0.01% 1133

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

Virtu Financial's BIOA Position: Q3 2025 in Review

Virtu Financial sold out of BioAge Labs (BIOA) in Q3 2025, closing a stake of 14,911 shares — an estimated $62K sold.

Virtu Financial first reported a position in BIOA in Q4 2024 and held it in 2 quarters. The position peaked at $62K in Q2 2025. 94 funds tracked by Wall St. Rank hold BIOA as of Q3 2025.

  • Virtu Financial reported no remaining BioAge Labs position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 14,911 BioAge Labs shares in Q3 2025, an estimated $62K.
  • Virtu Financial first reported a position in BioAge Labs in Q4 2024 and held it in 2 quarters.
  • Virtu Financial's BioAge Labs position peaked at $62K in Q2 2025.
  • 94 funds tracked by Wall St. Rank held BioAge Labs as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.